Kane Biotech Inc.
6-1200 Waverley Street
Winnipeg
Manitoba
R3T 0P4
Canada
Tel: 204-487-7412
Fax: 204-488-9823
Website: http://www.kanebiotech.com/
Email: info@kanebiotech.com
182 articles about Kane Biotech Inc.
-
Kane Biotech Inc. Appoints Board Advisor and Announces Private Placement Offering
11/2/2010
-
Kane Biotech Inc.'s DispersinB(R) Wound Spray Passes First Set of Biocompatibility Tests
10/4/2010
-
Kane Biotech Inc.'s DispersinB(R) Wound Spray Passes Quality Control and Sterility Tests
9/30/2010
-
Kane Biotech Inc. Develops DispersinB(R) Monoclonal Antibodies
9/21/2010
-
Kane Biotech Inc. Appoints Mr. Philip Renaud to Board of Directors
9/15/2010
-
Kane Biotech Inc. Appoints Dr. Jeffrey B. Kaplan to Scientific Advisory Board
7/20/2010
-
Kane Biotech Inc.'s Antibiofilm Technologies Published in Two New Scientific Books
2/23/2010
-
Kane Biotech Inc. Announces Grant of Options
1/25/2010
-
Kane Biotech Inc.'s DispersinB(R) Patent Issues In Australia
1/20/2010
-
Kane Biotech Inc. Announces Closing of Private Placement Offering
12/1/2009
-
Kane Biotech Inc. Announces Increase to Private Placement Offering
11/30/2009
-
Kane Biotech Inc. Announces Private Placement Offering
11/16/2009
-
Kane Biotech Inc. Granted Third United States Patent for Oral Care Technology
11/2/2009
-
Kane Biotech Inc.: DispersinB(R) Topical Wound Gel Passes First Set of Biocompatibility Tests
9/28/2009
-
Kane Biotech Inc. Announces Closing of Early Exercise Warrant Incentive Program
9/28/2009
-
Kane Biotech Inc. Enters Into a Cooperative Research and Development Agreement for Material Transfer With the U.S. Army's Walter Reed Army Institute of Research
9/8/2009
-
Kane Biotech Inc. Release: Harvard Medical School Study Finding Confirms the Presence of DispersinB(R) Biofilm Target in Combat Wound Infection-Associated Bacteria
9/2/2009
-
Kane Biotech Inc. Selected to Present at Biomedical Defence Conference in Washington, DC
8/19/2009
-
Kane Biotech Inc.'s DispersinB(R) Topical Wound Gel Manufacturing Completed
8/10/2009
-
Kane Biotech Inc. Announces Amendment to Warrant Terms and Early Exercise Warrant Incentive Program
8/6/2009